Results

Total Results: 904 records

Showing results for "author year description".

81. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cerebral-palsy-feeding_research-protocol.pdf
    June 12, 2012 - Data suggest that during the first year of life, 57 percent of children with CP have sucking problems … evidence table may vary by KQ as appropriate, but the tables will contain some common elements, such as author … , year of publication, population and intervention descriptions, sample size, key outcomes, and study … Prevalence of cerebral palsy among ten-year-old children in metropolitan Atlanta, 1985 through 1987. … A priori' methods of assessment should be provided (e.g., for effectiveness studies if the author(s

82. Disposition of Comments Report for Primary Care Management of Abnormal Uterine Bleeding (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_disposition-comments.pdf
    March 21, 2013 - See Woolcock 2008; Fraser and Critchley 2007; Munro and Critchley 2011 A description of terminology … Peer Reviewer #7 (TEP) Introduction p. 4 l.13-14 l. 23 This is too simplistic a description of … Line 23 “encourage endometrial quiescence” and “prevent growth” are the type of description I would … Results p. 26 l. 25 There is a RCT from Scandanavia comparing LNG-IUS with hysterectomy with 5+ year … This may not have been captured, but it is RCT with followup beyond a year.

83. Disposition of Comments for CER 170 Cultural Competence Health Disparities (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cultural-competence_disposition-comments.pdf
    January 01, 2020 - following UNCLEAR SENTENCE should be modified: Since evidence was sparse, qualitative analysis and description … TEP 3 Introduction Cultural Competence Section needs to include a description of the National Standards … Overall I found the description of what's eligible and what's not to be hard to follow given that there

84. Microsoft Word - 3-DKE274__ACEI-ARB-DRI__Comments_Disposition_Table-21_Jan_2011 cyk _2_.docx (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_disposition-comments.pdf
    October 07, 2011 - Executive Summary There is an incorrect description of the Renin-Angiotensin Aldosterone System ( … The description has been corrected and now matches the main report. … meaningful way (e.g., all the RCTs together, all the observational studies together, and then sorted by year … re-formatted the figures and tables to list RCTs and observational studies together in a group and then by year … Rather than having readers find the original GRADE papers, a very brief description of the relevant

85. Methods Future Research Needs Number 8: Framework for Considering Study Designs (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/study-design-framework_research.pdf
    March 01, 2012 - Power Calculations for Superiority RCTs for Various 5-year Primary Event Rates in the Comparator Arm … Power calculations for superiority RCTs for various 5-year primary event rates in the comparator arm11 … Plotted are power calculations for six different 5-year primary event rates in the comparator arm … Noncomparative Study Examples of this design include: A study that presents a description of a … Terms associated with study designs Term Description Cluster The term cluster refers to a unit of

86. FRN 30: Outpatient Case Management for Adults With Medical Illnesses and Complex Care Needs: Future Research Needs (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/case-management-future_research.pdf
    June 01, 2015 - The findings and conclusions in this document are those of the author(s), who are responsible for its … description/component 13 How medication management is done CM description/component 14 Care plan details … ) CM description/components 18 Family caregiver interventions CM description/components 19 In-patient … intervention CM description/components 20 Program components CM description/components 21 What happens … Recently Completed Studies/Projects on the Effectiveness of Case Management First Author, Year Objective

87. Disposition of Comments_Systematic Review: Mental Health and Occupational Stress in the Emergency Medical Services and 911 Workforce (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-911-workforce-mental-health-disposition-comments.pdf
    February 28, 2025 - Published Online: February 28, 2025 2 Peer Reviewer, Technical Expert, and Public Comments and Author … If the goal is to have this report used by people in the EMS industry, could a simplified description … It’s covered in the chart on p.7 but the description here is of added value (p.94, 97). … We have moved the description of EMS population to the Methods section (after we introduce the eligibility … As noted above, we have moved the description to the Methods section. 48 Peer Reviewer #2 Discussion

88. Version-3-Immunity-After-Covid-19-Appendix-Table-B-1 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
    January 24, 2022 - KQ1_IgG Duration_n=3 Observational studies examining IgG Duration Author Year Title PMID Link/URL … Country Study Design Length of follow-up (Months) Population category Population Description Data … Description Data Source Study Period Inclusion criteria Exclusion criteria Total N Age: Mean (SD) … Population category Population description Data source Inclusion criteria Exclusion criteria Positive … ≤1 year after primary infection: 6,111 F/u >1 year after primary infection: 474 Unvaccinated only

89. DEcIDE 34 - Developing a Registry of Patient Registries: Options for the Agency for Healthcare Research and Quality (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/registry-of-patient-registries-development_research_0.pdf
    February 01, 2012 - ..................... 24 Effective Health Care Program Research Report Number 34   iv   Author … In addition to a description of the reference population, it includes a full description of data elements … These efforts result in about 1,200 new project records being added each year. … Age of patients Sponsor Protocol IDs Trial description Summary of objectives Description, including … The current Clinicaltrials.gov results database has a budget of about $5 million per year, including

90. Disposition of Comments CER 194 Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-194-disposition-comments-inhaled-corticosteroids.pdf
    March 19, 2018 - Nonetheless the overall trend is increasing (despite year to year differences in direction and amount … Further description as to the domains that led to downgrading a given outcome are provided in the … Further description as to the domains that led to downgrading a given outcome within each intervention … Further description as to the domains that led to downgrading a given outcome within each intervention … Public reviewer #1, Anonymous KQ1c A description of how dosing (frequency and cumulative dose) differs

91. Disposition of Comments Report for Vitamin D and Calcium: A Systematic Review of Health Outcomes (Update) (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_disposition-comments.pdf
    September 15, 2014 - However we have now clarified the description and moved it so that it appears after the description … standard” and added more detail about the use of NIST and DEQAS standards as well as reporting the year … breast and colorectal cancer and for hip fracture conducted by Prentice and colleagues of the 7- year … Description of results in Table 33B report the increased risk at higher 25OHD levels. … MS, irrespective of year, country etc.

92. Disposition of Comments for Evidence Report 220 Health Information Exchange (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/health-information-exchange-disposition-160504.pdf
    December 15, 2015 - TEP Reviewer #5 Introduction A very clear description of the current state of the literature and its … Peer Reviewer #8 Results Page 29 line 12: out in the year as this will not stad the "test of time" … However the description of push system was not clear to me. c. … For example, a dump of all filled prescriptions organized by dispensing data for the last year will … The 5-year survival of all start-up businesses is about 10%.

93. Disposition of Comments Report for Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_disposition-comments.pdf
    June 07, 2013 - Please reword to provide a more detailed description We have revised the sentence to be more precise … primary focus was on the association between OC use and ovarian cancer, we chose a less restrictive year … compared to the other cancers of interest, we analyzed the results with both a more and less restrictive year … Would it be possible/helpful to stratify the 0-10 year interval into 2 intervals? … The reviewer is correct, and we have revised this description to clarify that probabilistic analysis

94. Disposition of Comments Report for Evidence Report/Technology Assessment No. 214 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/smoking-pregnancy-infants_disposition-comments.pdf
    February 25, 2014 - Multiple SAMHSA reports based on annual, representative household face to face surveys each year from … We contacted the author for clarification of the number of participants but did not receive a response … The evaluation covered year 1-2. … We contacted the author for clarification of the number of participants but did not receive a response … I am unaware of any inappropriate inclusions or exclusions, and, as a co-author of one of the studies

95. Disposition of Comments Report for Otitis Media With Effusion (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ear-infection_disposition-comments.pdf
    May 04, 2013 - We have added additional information in the report concerning this study, both a description of the … Peer Reviewer #8 General The description of the methods and he genral quality of the writing are … is for many children a dynamic and not a constant state and the notion of cases lasting more than a year … The author reports both best and worst ear and we have included both in our summary table. … Grammatical outcomes of 3 & 6 year old children with mild to severe hearing loss.

96. Stakeholder Involvement in Improving Comparative Effectiveness Reviews: AHRQ and the Effective Health Care Program (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholder-engagement_research.pdf
    September 01, 2011 - The findings and conclusions in this document are those of the author(s), who are responsible for its … Chicago, IL Corresponding author: Howard Balshem Oregon Health & Science University 3181 SW Sam … The Stakeholder Group members are appointed for 2-year terms. … survival • Direct or indirect comparisons • Applicability or generalizability of evidence (i.e., description … • Harms ONGOING AND FUTURE RESEARCH • Description of current research that may inform decisionmaking

97. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
    March 10, 2010 - Methods We find it unfortunate that the literature searches ended over a year ago. … Considerable literature has been published in the past year that is directly relevant to the subject … A systematic review that fails to include information that is as much as a year old is not a useful … Timelines: Letters from Chalmers to lead authors: April 16 to May 2, 2008 Forwarded to Merck by lead author … in the population description with ?muscle-related side effects.?

98. Disposition of Comments for Pressure Ulcer Treatment Strategies: Comparative Effectiveness (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_disposition-comments.pdf
    May 08, 2013 - These have been added to the description. … about the exclusion of other systematic reviews which looked at comparative treatments that the author … The author is an ex-Board member of NPUAP. Summary: The rate of closure was 50% at 4-weeks. … This author also recognized that 'more recently developed pressure- relieving systems might be cost … Thus, for a clinical problem that may costs 11 billion dollars a year, we need evidence of what works

99. Improving the Management of Menopausal Symptoms in Perimenopausal and Early Postmenopausal Women: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopausal-symptoms-protocol.pdf
    October 15, 2024 - cycle length, with elevated but variable follicle-stimulating hormone (FSH, >25 IU/L), and through 1 year … menopause, premature menopause, early menopause • Early perimenopausal women (prior to and through 1 year … menopause, premature menopause, early menopause • Early perimenopausal women (prior to and through 1 year … Any protocol amendments will be listed in this section with the date of the amendment, a description … or therap*)).ti,bt,ab,kf. 155871 29 Structure # Searches Results Description 59 (

100. Disposition of Comments Report for Stroke Prevention in Atrial Fibrillation (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_disposition-comments.pdf
     August 23, 2013 - for non-inferiority; 1.7% per year vs. 2.2% per year for rivaroxaban and warfarin, respectively; HR … Excellent description of results. … Rates were: 0.26% per year for rivaroxaban vs. 0.44% per year for warfarin. … Rates were: 0.04% per year for rivaroxaban vs. 0.19% per year for warfarin. … Rates were: 1.53% per year for rivaroxaban vs. 1.71% per year for warfarin.